Beyond a shadow of a reasonable doubt the government is in the pocket of the drug industry. From Joseph Mercola at lewrockwell.com:
July 22, 2020, Pfizer struck a $1.95 billion deal with the U.S. Department of Health and Human Services and the Department of Defense to provide Americans with 100 million doses of its COVID-19 vaccine, for free, with an option for 500 million additional doses.1 The agreement is part of Operation Warp Speed.
Pfizer/BioNTech have also inked a deal with the U.K. government for 30 million initial doses.2 The vaccine, currently known only as BNT162, developed in partnership with the German company BioNTech, requires two doses, which means the initial batch for the U.S. would cover 50 million people. The deal hinges on the vaccine clearing Phase 3 human trials.
According to a July 22, 2020, press release,3 Phase 2b/3 safety and efficacy trials were expected to begin at the end of July. The company expects seeking a regulatory review by the U.S. Food and Drug Administration in October 2020, which would allow them to manufacture the 100 million doses by the end of the year.
The BNT162 vaccine is based on BioNTech’s proprietary mRNA technology. BioNTech is the market authorization holder for the mRNA technology worldwide, and will own all the trademarks for the vaccine.5 According to Pfizer’s press release:6
“The Pfizer/BioNTech vaccine development program is evaluating at least four experimental vaccines, each of which represents a unique combination of messenger RNA (mRNA) format and target antigen. On July 1st, Pfizer and BioNTech announced preliminary data7 from BNT162b1, the most advanced of the four mRNA formulations.
The data demonstrates that BNT162b1 is able to produce neutralizing antibodies in humans at or above the levels observed in the plasma from patients who have recovered from COVID-19 … Local reactions and systemic events were dose-dependent, generally mild to moderate, and transient. No serious adverse events were reported.”